• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agfa/Sterling deal clears hurdles

Article

Agfa’s proposed acquisition of Sterling Diagnostic Imaging received the go-ahead from regulatory authorities in the U.S. and Europe, the companies reported this month. Executives from the firms believe that the merger should be completed by the

Agfa’s proposed acquisition of Sterling Diagnostic Imaging received the go-ahead from regulatory authorities in the U.S. and Europe, the companies reported this month. Executives from the firms believe that the merger should be completed by the middle of May, pending shareholder approval (SCAN 1/20/99). Agfa’s spin-off from Bayer could come as soon as a month later, with Bayer setting a deadline of June 1 for the divestiture of its Mortsel, Belgium-based subsidiary, according to Bloomberg News.

Sterling of Greenville, SC, is also reportedly close to reaching a deal to sell off its Direct Radiography Corp. digital x-ray subsidiary, which is not part of the Agfa sale. Sources close to Sterling say that it has received bids from a number of prospective suitors for DRC, and plans to make a decision in the next several weeks.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.